Physician profile
Steven Ryan Facer
NPI 1942327697
$846,721.89
in general payments reported to CMS, 2019-2025
9 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Endodontics providers received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395K · 2020: $99K · 2021: $79K · 2022: $84K · 2023: $41K · 2024: $84K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $178K · Travel and Lodging: $4,513 · Food and Beverage: $3,698 · Education: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $177,904.71 |
| Travel and Lodging | $4,512.79 |
| Food and Beverage | $3,698.14 |
| Education | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonendo INC | $843,115.95 | 2019-2025 | Gentlewave G4 Console, Posterior Cleanflow Procedure Instrument With Matrices, Gentlewave Console |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Dentsply Ih INC. | $944.94 | 2019 | |
| Tulsa Dental Products LLC | $570.29 | 2019 | |
| Dentsply Sirona INC | $409.33 | 2019 | |
| Nusmile, Ltd. | $142.60 | 2023 | Neosealer, Neoputty, Neomta |
| Straumann USA LLC | $24.18 | 2019 | |
| Vatech America, INC. | $14.60 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Facer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.